{
    "Trade/Device Name(s)": [
        "Rapid Tox Cup"
    ],
    "Submitter Information": "American Bio Medica Corporation",
    "510(k) Number": "K073078",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041712",
        "K023869",
        "K053359"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LAG",
        "DJG",
        "DIO",
        "DKE",
        "LCM",
        "DKZ",
        "JXM",
        "DJR",
        "LFI",
        "JXN"
    ],
    "Summary Letter Date": "May 13, 2008",
    "Summary Letter Received Date": "May 14, 2008",
    "Submission Date": "May 7, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Methamphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Methamphetamine",
        "3,4-methylenedioxymethamphetamine (MDMA)",
        "Buprenorphine",
        "Benzodiazepines (Oxazepam)",
        "Barbiturates (Butalbital)",
        "Oxycodone",
        "Methadone",
        "Phencyclidine",
        "Propoxyphene",
        "Opiates",
        "Cocaine (Benzoylecgonine)",
        "Tricyclic Antidepressants (Nortriptyline)",
        "THC/Cannabinoids (11-nor-\u03949-THC-9-carboxylic acid)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Polypropylene cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Rapid Tox Cup, a lateral flow immunoassay in cup format for qualitative detection of multiple drugs of abuse in urine.",
    "Indications for Use Summary": "Intended for professional use in the qualitative detection of 14 drugs of abuse in human urine using a one-step lateral flow immunoassay in a polypropylene cup, providing preliminary results to determine the need for confirmatory testing.",
    "fda_folder": "Toxicology"
}